PharmaCyte Biotech, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 0.3321 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.57M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company’s cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.
Details
| Name | PharmaCyte Biotech, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 2 |
| Founded | 1996 |
| Ceo | Joshua Silverman |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | May - April |
| Reporting Currency | USD |
| Isin | US71715X2036 |
| Cusip | 71715X203 |
| Cik | 1157075 |
| Sic | 2836 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Joshua N. Silverman | Chief Executive Officer. President and Executive Chairman |
| Carlos A. Trujillo CPA | Chief Financial Officer |
| Dr. Jose L. Iglesias M.D. | Consulting Chief Medical Officer |
| Dr. Hans-Peter Hammes M.D. | Member of Medical and Scientific Advisory Board and Consultant |
Contact
| Address | 3960 Howard Hughes Parkway, Suite 500, Las Vegas, Nevada 89169, United States |
| Phone | 917 595 2850 |
| Website | https://pharmacyte.com |